0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Drug Therapy
 41-60 of 59 Articles
Article |  FREE
Chris Feudtner, MD, PhD, MPH; Dingwei Dai, PhD; Kari R. Hexem, MPH; et al.
Arch Pediatr Adolesc Med. 2012;166(1):9-16. doi:10.1001/archpediatrics.2011.161.
Includes: CME, Supplemental Content

Article |  FREE
H. Shonna Yin, MD, MS; Alan L. Mendelsohn, MD; Michael S. Wolf, PhD, MPH; et al.
Arch Pediatr Adolesc Med. 2010;164(2):181-186. doi:10.1001/archpediatrics.2009.269.

The Pediatric Forum | 
Murli U. Purswani, MD; Jolly Radhakrishnan, MD; Khudsia R. Irfan, MD; et al.
Arch Pediatr Adolesc Med. 2009;163(2):186-188. doi:10.1001/archpediatrics.2008.541.

The Pediatric Forum | 
George R. Kim, MD; Allen R. Chen, MD, PhD; Robert J. Arceci, MD, PhD; et al.
Arch Pediatr Adolesc Med. 2006;160(11):1185-1186. doi:10.1001/archpedi.160.11.1185-b.

Article |  FREE
Rita Mangione-Smith, MD, MPH; Marc N. Elliott, PhD; Tanya Stivers, PhD; et al.
Arch Pediatr Adolesc Med. 2006;160(9):945-952. doi:10.1001/archpedi.160.9.945.

The Pediatric Forum | 
Barton D. Schmitt, MD
Arch Pediatr Adolesc Med. 2006;160(7):757. doi:10.1001/archpedi.160.7.757-a.

Editorial | 
Frederick P. Rivara, MD, MPH
Arch Pediatr Adolesc Med. 2005;159(7):685. doi:10.1001/archpedi.159.7.685.

The Pediatric Forum | 
Bradley C. Johnston, ND; Ping Wu, MBBS; Edward Mills, DPH, MSc
Arch Pediatr Adolesc Med. 2005;159(7):690-692. doi:10.1001/archpedi.159.7.692.

Evidence-Based Journal Club |  FREE
Cynthia M. Rand, MD, MS; Kelly M. Conn, BS; Crista N. Crittenden, BA; et al.
Arch Pediatr Adolesc Med. 2004;158(7):625-627. doi:10.1001/archpedi.158.7.625.

Article |  FREE
Karen S. Frush, MD; Xuemei Luo, PhD; Paul Hutchinson, BS; et al.
Arch Pediatr Adolesc Med. 2004;158(7):620-624. doi:10.1001/archpedi.158.7.620.

Article |  FREE
Emanuel O. Doyne, MD; Mary Pat Alfaro, MS, RD; Robert M. Siegel, MD; et al.
Arch Pediatr Adolesc Med. 2004;158(6):577-583. doi:10.1001/archpedi.158.6.577.

Article |  FREE
Carol L. Freund, PhD; David F. Gregory, PharmD; Ellen Wright Clayton, MD, JD
Arch Pediatr Adolesc Med. 2004;158(3):276-279. doi:10.1001/archpedi.158.3.276.

Article |  FREE
Maureen E. Schuler, PhD; Prasanna Nair, MD, MPH; Laurie Kettinger, MS
Arch Pediatr Adolesc Med. 2003;157(2):133-138. doi:10.1001/archpedi.157.2.133.

Editorial | 
Michael S. Jellinek, MD
Arch Pediatr Adolesc Med. 2003;157(1):14-16. doi:10.1001/archpedi.157.1.14.

Article |  FREE
Mark T. Holdsworth, PharmD; Richard E. Fichtl, PharmD; Maryam Behta, PharmD; et al.
Arch Pediatr Adolesc Med. 2003;157(1):60-65. doi:10.1001/archpedi.157.1.60.

Article |  FREE
Rainu Kaushal, MD, MPH; Kenneth N. Barker, PhD; David W. Bates, MD, MSc
Arch Pediatr Adolesc Med. 2001;155(9):1002-1007. doi:10.1001/archpedi.155.9.1002.

The Pediatric Forum | 
Craig G. Burkhart, MSPH, MD; Kristiina M. Burkhart; A. Kristiina Burkhart, MBA, CPA, JD
Arch Pediatr Adolesc Med. 1998;152(6):609-610. doi:.

The Pediatric Forum | 
Richard P. Kidwell, JD
Arch Pediatr Adolesc Med. 1998;152(6):610. doi:.

Article |  FREE
Timothy S. Lesar, PharmD
Arch Pediatr Adolesc Med. 1998;152(4):340-344. doi:10.1001/archpedi.152.4.340.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA
Viewpoint  | 
Evaluation of Flibanserin Science and Advocacy at the FDA
Walid F. Gellad, MD, MPH; Kathryn E. Flynn, PhD; G. Caleb Alexander, MD, MS
JAMA Psychiatry
Original Investigation  | 
Evaluation of Antipsychotic Dose Reduction in Late-Life Schizophrenia A Prospective Dopamine D2/3 Receptor Occupancy Study
Ariel Graff-Guerrero, MD, PhD; Tarek K. Rajji, MD; Benoit H. Mulsant, MD, MS; et al.
JAMA Oncology
From The JAMA Network  | 
Prognostic Significance of Cutaneous Adverse Events Associated With Pembrolizumab Therapy
Jennifer A. Lo, BA; David E. Fisher, MD, PhD; Keith T. Flaherty, MD
JAMA
The JAMA Forum  | 
A New Focus on Prescription Drug Spending
Gail Wilensky, PhD